Evidence map›Paper›PMID 21306571›Full record

ArticleInfluenza and other respiratory viruses2011

Canada in the face of the 2009 H1N1 pandemic.

Seyed M Moghadas, Nick J Pizzi, Jianhong Wu, Susan E Tamblyn, David N Fisman

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Mathematical modelling for pandemic preparedness in Canada: Learning from COVID-19.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Improving public health policy through infection transmission modelling: Guidelines for creating a Community of Practice.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale
    Article
  13. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Seyed M MoghadasInstitute for Biodiagnostics, National Research Council Canada, Winnipeg, MB, Canada. Seyed.Moghadas@nrc-cnrc.gc.ca
Nick J Pizzi
Jianhong Wu
Susan E Tamblyn
David N Fisman

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundInitial public health responses to the 2009 influenza H1N1 pandemic were based on difficult decisions in the face of substantial uncertainty. Policy effectiveness depends critically on such decisions, and future planning for maximum protection of community health requires understanding of the impact of public health responses in observed scenarios.

objectivesIn alignment with the objectives of the Pandemic Influenza Outbreak Research Modelling Team (Pan-InfORM) and the Centre for Disease Modelling (CDM), a focused workshop was organized to: (i) evaluate Canada's response to the spring and autumn waves of the novel H1N1 pandemic; (ii) learn lessons from public health responses, and identify challenges that await public health planners and decision-makers; and (iii) understand how best to integrate resources to overcome these challenges.

main outcome measuresWe report on key presentations and discussions that took place to achieve the objectives of the workshop.

conclusionsFuture emerging infectious diseases are likely to bring far greater challenges than those imposed by the 2009 H1N1 pandemic. Canada must address these challenges and enhance its capacity for emergency responses by integrating modelling, surveillance, planning, and decision-making.

Indexed as

Influenza A Virus, H1N1 SubtypePandemicsAntiviral AgentsCanadaHumansInfluenza, HumanInfluenza VaccinesPublic HealthVaccinationAntiviral AgentsInfluenza Vaccines

Identifiers

PMID21306571
PMCPMC4942003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.